Skip to main content

ADVERTISEMENT

Videos

Videos
06/27/2024
Ashley Margol, MD, discusses the course of treatment she would take for a patient with pediatric low-grade glioma.
Ashley Margol, MD, discusses the course of treatment she would take for a patient with pediatric low-grade glioma.
Ashley Margol, MD, discusses the...
06/27/2024
Oncology
Matthew Matasar, MD
Videos
06/27/2024
Matthew Matasar, MD, shares expert insights into the current and evolving “potentially practice-changing” clinical trial research landscape for the treatment of patients with diffuse large B-cell lymphoma.
Matthew Matasar, MD, shares expert insights into the current and evolving “potentially practice-changing” clinical trial research landscape for the treatment of patients with diffuse large B-cell lymphoma.
Matthew Matasar, MD, shares...
06/27/2024
Oncology
Videos
06/26/2024
Lyudmila Bazhenova, MD, discusses the course of treatment she would take for a patient with early-stage non-small cell lung cancer.
Lyudmila Bazhenova, MD, discusses the course of treatment she would take for a patient with early-stage non-small cell lung cancer.
Lyudmila Bazhenova, MD,...
06/26/2024
Oncology
Murugesan Figure 1
Clinical Videos
06/26/2024
Video Supplement to "Vanishing Right Atrial Thrombus" (Clinical Image).
Video Supplement to "Vanishing Right Atrial Thrombus" (Clinical Image).
Video Supplement to "Vanishing...
06/26/2024
Journal of Invasive Cardiology
Marita Kametas
Rapid Refresh
06/26/2024
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from...
06/26/2024
APP Institute Inflammatory Bowel Disease
Moritz Furstenau, MD
Conference Coverage
06/26/2024
At the 65th ASH Annual Meeting, Moritz Furstenau, MD, presented a follow-up analysis of the CLL2-Baag trial on the efficacy and ctDNA analysis of acalabrutinib, venetoclax, and obinutuzumab combination therapy after optional debulking with...
At the 65th ASH Annual Meeting, Moritz Furstenau, MD, presented a follow-up analysis of the CLL2-Baag trial on the efficacy and ctDNA analysis of acalabrutinib, venetoclax, and obinutuzumab combination therapy after optional debulking with...
At the 65th ASH Annual Meeting,...
06/26/2024
Oncology
Aaron Gerds, MD
Videos
06/25/2024
Aaron Gerds, MD, discusses data from the MANIFEST-2 and TRANSFORM-1 trials exploring first-line treatment options for patients with myelofibrosis, as well as analyzes the establishment of optimal clinical trial end points.
Aaron Gerds, MD, discusses data from the MANIFEST-2 and TRANSFORM-1 trials exploring first-line treatment options for patients with myelofibrosis, as well as analyzes the establishment of optimal clinical trial end points.
Aaron Gerds, MD, discusses data...
06/25/2024
Oncology
Kirby
Videos
06/25/2024
Dr. Kirby spoke to Podiatry Today about his session at the Western Foot and Ankle Conference.
Dr. Kirby spoke to Podiatry Today about his session at the Western Foot and Ankle Conference.
Dr. Kirby spoke to Podiatry...
06/25/2024
Podiatry Today
Aaron Gerds, MD
Videos
06/24/2024
Aaron Gerds, MD, presents insights into data from a study in which luspatercept improved anemia and transfusion burden for patients with myelofibrosis, and explains next steps for investigating luspatercept in further clinical trials.
Aaron Gerds, MD, presents insights into data from a study in which luspatercept improved anemia and transfusion burden for patients with myelofibrosis, and explains next steps for investigating luspatercept in further clinical trials.
Aaron Gerds, MD, presents...
06/24/2024
Oncology